The following income statements and other information are available for the Ceradyne Company:

		2020		2019		2018
Sales		$311,600,000		$205,000,000		$155,800,000
Less cost of goods sold		172,200,000		98,400,000		74,620,000
Gross margin		139,400,000		106,600,000		81,180,000
Less:
Selling and administrative costs		22,550,000		20,295,000		16,055,600
Research and development		12,511,200		10,168,000		7,749,000
Income from operations		104,338,800		76,137,000		57,375,400
Less taxes on income		20,867,760		15,227,400		11,475,080
Net income		$83,471,040		$60,909,600		$45,900,320
Total assets		$586,300,000		$545,300,000		$361,620,000
Noninterest-bearing current liabilities		11,480,000		9,266,000		8,101,600
Cost of capital		12%		12%		12%

Calculate EVA for 2020. Assume that for purposes of calculating EVA, the company capitalizes research and development expenditures and amortizes them over three years, including the year they are incurred. For external reporting purposes, research and development is expensed in the year incurred, as indicated in the income statements above. (Round answer to the nearest whole dollar, e.g. 5,725. Enter negative answers preceding either - sign, e.g. -45 or in parentheses, e.g. (45).)

EVA for 2020

$